SPDR S&P Biotech ETF Rating → He Is Giving Away Bitcoin (From Crypto Swap Profits) (Ad) Free XBI Stock Alerts $89.02 -0.09 (-0.10%) (As of 05/9/2024 ET) Add Compare Share Share RatingsStock AnalysisChartHeadlinesHoldingsOwnershipRatingsStock AnalysisChartHeadlinesHoldingsOwnershipRatings SPDR S&P Biotech ETF Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.XBI Aggregate RatingModerate Buy2.74Holdings in XBI have an aggregate rating of Moderate Buy based on 589 analyst ratings issued in the past year covering 50 companies (54.1% of the portfolio).XBI Aggregate Price Target$119.2733.98% UpsideHigh Prediction$158.71Average Prediction$119.27Low Prediction$82.11Holdings in XBI have an aggregate price target of $119.27 and a range of $82.11 to $158.71 covering 50 companies (54.1% of the portfolio).XBI Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy15 Buy rating(s)Moderate Buy27 Moderate Buy rating(s)Hold7 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by SPDR S&P Biotech ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 50 XBI Holdings Export to ExcelWeightIn ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings1.88%ALPNAlpine Immune Sciences$64.82+0.2%2 of 5 stars2.27$50.33 -22.3%111.32%RVMDRevolution Medicines$37.45-2.2%4 of 5 stars3.10$41.20 10.0%10Earnings ReportAnalyst ForecastNews Coverage1.30%IBRXImmunityBio$8.06+1.8%0 of 5 stars2.00$6.00 -25.6%1Gap Up1.26%VKTXViking Therapeutics$80.20+0.4%4 of 5 stars3.00$112.25 40.0%101.22%MRNAModerna$122.69+0.7%4 of 5 stars2.25$126.89 3.4%16Earnings ReportAnalyst ForecastAnalyst Revision1.20%EXELExelixis$21.76+0.8%5 of 5 stars2.63$26.33 21.0%16Analyst Revision1.19%NTRANatera$95.55-0.1%2 of 5 stars3.00$86.40 -9.6%14Upcoming EarningsHigh Trading Volume1.18%CRNXCrinetics Pharmaceuticals$49.42-2.9%4 of 5 stars2.92$57.58 16.5%12Analyst ForecastNews Coverage1.18%CERECerevel Therapeutics$42.30+0.6%0 of 5 stars2.11$42.67 0.9%91.18%GERNGeron$3.88+1.8%4 of 5 stars2.80$6.10 57.2%5Analyst RevisionGap Down1.17%PTCTPTC Therapeutics$31.05-0.3%2 of 5 stars1.92$33.67 8.4%131.16%SRPTSarepta Therapeutics$132.30-0.2%4 of 5 stars2.79$160.60 21.4%14Insider SellingAnalyst Revision1.16%ROIVRoivant Sciences$11.25+0.4%4 of 5 stars2.90$16.90 50.2%10Positive News1.14%AMGNAmgen$312.86+1.8%5 of 5 stars2.52$305.05 -2.5%21Earnings ReportAnalyst ForecastAnalyst Revision1.13%BPMCBlueprint Medicines$108.34-0.4%1 of 5 stars2.50$100.31 -7.4%16Analyst ForecastInsider SellingAnalyst Revision1.12%NBIXNeurocrine Biosciences$139.66+0.5%5 of 5 stars2.74$147.88 5.9%23Analyst Revision1.12%EXASExact Sciences$54.15-9.0%4 of 5 stars2.92$99.07 82.9%14Analyst ForecastNews CoverageGap DownHigh Trading Volume1.10%UTHRUnited Therapeutics$266.05+1.9%5 of 5 stars2.90$308.78 16.1%10Insider Selling1.09%ALNYAlnylam Pharmaceuticals$151.37-0.6%5 of 5 stars2.59$216.19 42.8%17Earnings ReportAnalyst Forecast1.09%BIIBBiogen$222.75+1.4%5 of 5 stars2.65$290.92 30.6%261.08%RYTMRhythm Pharmaceuticals$38.50-1.1%3 of 5 stars2.83$54.33 41.1%6Earnings ReportAnalyst ForecastNews Coverage1.08%VRTXVertex Pharmaceuticals$418.99+0.0%4 of 5 stars2.48$432.18 3.1%25Earnings ReportAnalyst Forecast1.08%DYNDyne Therapeutics$25.95+1.0%3 of 5 stars3.13$37.75 45.5%8Analyst ForecastAnalyst RevisionNews Coverage1.07%IONSIonis Pharmaceuticals$39.47-1.7%4 of 5 stars2.71$59.54 50.8%14Earnings ReportAnalyst ForecastInsider SellingNews CoverageGap Down1.07%BMRNBioMarin Pharmaceutical$81.72-0.1%5 of 5 stars2.63$107.50 31.5%19Insider Selling1.06%CYTKCytokinetics$64.02-1.9%4 of 5 stars2.87$79.33 23.9%15Earnings ReportAnalyst ForecastInsider SellingNews CoverageGap Up1.05%REGNRegeneron Pharmaceuticals$968.00+1.3%4 of 5 stars2.70$981.71 1.4%201.04%HALOHalozyme Therapeutics$43.84+4.4%5 of 5 stars2.86$53.14 21.2%7Analyst ForecastNews Coverage1.04%SWTXSpringWorks Therapeutics$42.95+1.6%2 of 5 stars3.00$68.83 60.3%6Earnings ReportAnalyst ForecastAnalyst Revision1.03%ABBVAbbVie$160.380.0%4 of 5 stars2.77$174.31 8.7%13Earnings Report1.01%IDYAIDEAYA Biosciences$40.64-1.9%3 of 5 stars3.00$47.50 16.9%12Earnings ReportUpcoming EarningsAnalyst ForecastAnalyst RevisionNews Coverage1.01%BBIOBridgeBio Pharma$28.73+3.7%4 of 5 stars2.80$47.82 66.4%101.01%KRYSKrystal Biotech$158.74+0.7%4 of 5 stars3.00$171.00 7.7%9Earnings ReportAnalyst ForecastAnalyst RevisionNews Coverage1.01%INSMInsmed$26.38+1.5%4 of 5 stars3.00$44.92 70.3%12Analyst DowngradeNews CoverageGap Up0.99%INCYIncyte$53.500.0%5 of 5 stars2.47$74.93 40.1%17Gap Down0.99%IMVTImmunovant$29.70-0.2%3 of 5 stars3.00$48.00 61.6%17Positive News0.99%GILDGilead Sciences$64.58-0.5%5 of 5 stars2.39$83.69 29.6%180.98%VCELVericel$48.65+2.0%1 of 5 stars3.00$46.40 -4.6%6Earnings ReportAnalyst ForecastNews Coverage0.98%SNDXSyndax Pharmaceuticals$21.97-1.8%4 of 5 stars2.90$34.42 56.7%11Earnings ReportAnalyst ForecastNews Coverage0.98%DVAXDynavax Technologies$11.01-5.5%4 of 5 stars2.75$25.00 127.1%4Analyst ForecastNews CoverageGap DownHigh Trading Volume0.98%IRWDIronwood Pharmaceuticals$6.74-17.0%4 of 5 stars3.00$19.80 193.8%5News CoverageGap Down0.96%RAREUltragenyx Pharmaceutical$41.22-0.8%4 of 5 stars2.92$87.85 113.1%12Earnings ReportAnalyst Forecast0.95%ALKSAlkermes$24.26+0.7%5 of 5 stars2.50$35.38 45.8%10Analyst Revision0.95%PCVXVaxcyte$65.57-1.8%1 of 5 stars3.00$78.50 19.7%4Earnings ReportAnalyst ForecastNews CoveragePositive NewsGap Down0.95%TWSTTwist Bioscience$43.20+4.3%2 of 5 stars3.00$42.50 -1.6%6Earnings ReportAnalyst ForecastInsider Selling0.93%TGTXTG Therapeutics$16.92-1.2%4 of 5 stars2.83$29.83 76.3%6Analyst Revision0.93%NUVLNuvalent$67.520.0%2 of 5 stars2.90$90.78 34.4%10Insider SellingNews Coverage0.92%FOLDAmicus Therapeutics$9.48-6.5%4 of 5 stars3.00$20.00 111.0%3News CoverageHigh Trading Volume0.91%MDGLMadrigal Pharmaceuticals$206.92-0.5%5 of 5 stars2.73$351.45 69.9%11Earnings ReportAnalyst ForecastNews Coverage0.91%CPRXCatalyst Pharmaceuticals$15.65+6.3%5 of 5 stars3.00$26.43 68.9%5News Coverage This page (NYSEARCA:XBI) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersThe A.I. story nobody is telling you (Read ASAP)TradeSmithThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsGold Set to EXPLODE!Gold Safe ExchangeThe Crypto 9-5 Escape PlanCrypto 101 MediaThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeTrue Market InsidersObama’s Forever Term [exposed]Porter & Company348 million Americans lives to END as we know it?The Oxford Club Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SPDR S&P Biotech ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
